skip to Main Content

Pancreatic Cancer Screening Solely Based on Glycated Hemoglobin Level Not Effective

Newsfeed image, light gray text on dark gray background
Based on findings published in JAMA Network Open, screening patients for pancreatic cancer based solely on elevation in glycated hemoglobin (HbA1c) level is not likely to represent an effective approach.

Given this, researchers indicated that alternative approaches to risk stratification are still necessary for patients with pancreatic cancer to improve early detection. Read more . . . 

Back To Top